167 related articles for article (PubMed ID: 218749)
1. Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention.
Frölich JC; Hollifield JW; Michelakis AM; Vesper BS; Wilson JP; Shand DG; Seyberth HJ; Frölich WH; Oates JA
Circ Res; 1979 Jun; 44(6):781-7. PubMed ID: 218749
[TBL] [Abstract][Full Text] [Related]
2. Suppression of plasma renin activity by indomethacin in man.
Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
[TBL] [Abstract][Full Text] [Related]
3. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the mechanism of action of prostaglandin synthesis inhibitors on renin and aldosterone secretion and sodium excretion.
Papanicolaou N; Papadakis G; Papanicolaou P; Theodorakopoulos P; Paris M; Dontas A; Paris M; Bariety J; Milliez P
Prostaglandins Med; 1981 Aug; 7(2):163-81. PubMed ID: 6792644
[TBL] [Abstract][Full Text] [Related]
5. Effect of selective inhibition of the inducible cyclooxygenase on renin release in healthy volunteers.
Stichtenoth DO; Wagner B; Frölich JC
J Investig Med; 1998 Aug; 46(6):290-6. PubMed ID: 9737091
[TBL] [Abstract][Full Text] [Related]
6. Adrenergically induced renin release in conscious indomethacin-treated dogs and rats.
Seymour AA; Davis JO; Echtenkamp SF; Dietz JR; Freeman RH
Am J Physiol; 1981 Jun; 240(6):F515-21. PubMed ID: 7018258
[TBL] [Abstract][Full Text] [Related]
7. Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers.
Stichtenoth DO; Marhauer V; Tsikas D; Gutzki FM; Frölich JC
Kidney Int; 2005 Nov; 68(5):2197-207. PubMed ID: 16221219
[TBL] [Abstract][Full Text] [Related]
8. Effects of indomethacin on plasma renin activity in the conscious rat.
Suzuki S; Franco-Saenz R; Tan SY; Mulrow PJ
Am J Physiol; 1981 Mar; 240(3):E286-9. PubMed ID: 7011052
[TBL] [Abstract][Full Text] [Related]
9. Influence of adrenergic nervous and prostaglandin systems on hydralazine-induced renin release.
Sinaiko AR
Life Sci; 1983 Dec; 33(23):2269-75. PubMed ID: 6316059
[TBL] [Abstract][Full Text] [Related]
10. Effect of prostaglandin E1 on renin and aldosterone in hypertensive patients.
Yoshimura M; Takahashi H; Takashina R; Kajita Y; Miyazaki T; Hachiya T; Ijichi H; Ochi Y
Endocrinol Jpn; 1979 Aug; 26(4):481-6. PubMed ID: 499089
[TBL] [Abstract][Full Text] [Related]
11. The effect of prostaglandin inhibition on renin release. A comparison of furosemide and low-sodium stimulation tests.
Goldiner WH; Valente WA; Hamilton BP; Mersey JH
J Lab Clin Med; 1981 Dec; 98(6):929-37. PubMed ID: 7031155
[TBL] [Abstract][Full Text] [Related]
12. The role of urinary PGE2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension.
Ruilope L; Garcia Robles R; Barrientos A; Bernis C; Alcazar J; Tresguerres JA; Mancheño E; Millet VG; Sancho J; Rodicio JL
Clin Exp Hypertens A; 1982; 4(6):989-1000. PubMed ID: 7047008
[TBL] [Abstract][Full Text] [Related]
13. Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.
Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Imai Y; Saito K; Sakurai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
Tohoku J Exp Med; 1979 May; 128(1):31-7. PubMed ID: 452004
[No Abstract] [Full Text] [Related]
14. [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].
Stumpe KO; Vetter H; Hessenbruch V; Düsing R; Kolloch R; Krück F
Klin Wochenschr; 1975 Oct; 53(19):907-11. PubMed ID: 241876
[TBL] [Abstract][Full Text] [Related]
15. Effect of propranolol on the urinary excretion of prostaglandin E and plasma renin activity in hypertensive patients.
Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Sato K; Imai Y; Sakurai Y; Ito T; Omata K; Yoshinaga K
Prostaglandins Med; 1980 Jul; 5(1):1-9. PubMed ID: 6996018
[TBL] [Abstract][Full Text] [Related]
16. Sulindac is not renal sparing in man.
Roberts DG; Gerber JG; Barnes JS; Zerbe GO; Nies AS
Clin Pharmacol Ther; 1985 Sep; 38(3):258-65. PubMed ID: 4028619
[TBL] [Abstract][Full Text] [Related]
17. Influence of indomethacin on the natriuretic and renin-stimulating effect of bumetanide in essential hypertension.
Pedrinelli R; Magagna A; Arzilli F; Sassano P; Salvetti A
Clin Pharmacol Ther; 1980 Dec; 28(6):722-31. PubMed ID: 7002429
[TBL] [Abstract][Full Text] [Related]
18. The effect of sodium restriction and prostaglandin inhibition on the renin-angiotensin system in man.
Speckart P; Zia P; Zipser R; Horton R
J Clin Endocrinol Metab; 1977 May; 44(5):832-7. PubMed ID: 870512
[TBL] [Abstract][Full Text] [Related]
19. Reduction by indomethacin of furosemide effects in the rabbit.
Oliw E; Kövér G; Larsson C; Anggård E
Eur J Pharmacol; 1976 Jul; 38(1):95-100. PubMed ID: 954837
[TBL] [Abstract][Full Text] [Related]
20. The effect of oxprenolol and indomethacin on renin and aldosterone of normal subjects during low sodium diet.
Pedrinelli R; Magagna A; Salvetti A
Eur J Clin Invest; 1982 Apr; 12(2):107-11. PubMed ID: 6807681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
